UCKL1 Activators
UCKL1 Activators are a class of compounds that either serve as direct substrates or indirectly enhance the enzymatic function of UCKL1. UCKL1, a kinase involved in the phosphorylation of uridine and cytidine nucleotides, plays an essential role in the synthesis of RNA. Direct activators such as CTP, ATP, and UTP provide the necessary substrates for the kinase activity of UCKL1. CTP and UTP are substrates that UCKL1 converts into their respective triphosphate forms, while ATP donates the phosphate groups required for this conversion. The presence of these nucleotides directly influences the activity of UCKL1 by providing the substrates and energy necessary for its function.
Furthermore, magnesium ions are vital as they act as cofactors, ensuring that UCKL1 maintains its structural conformation necessary for substrate binding and catalysis. Some flavonoids, due to their kinase-modulating properties, might also interact with UCKL1 and enhance its activity by mimicking its natural substrates. Indirect activators such as allopurinol and inosine, by modifying the balance of purine synthesis, can lead to compensatory mechanisms in pyrimidine synthesis, thereby enhancing the activity of UCKL1. Orotic acid increases the pool of substrates that UCKL1 can act upon, while compounds like leucovorin and methotrexate, by influencing thymidylate synthesis, indirectly affect the pyrimidine nucleotide synthesis in which UCKL1 participates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP provides the phosphate groups that UCKL1 uses to phosphorylate substrates such as UTP or CTP, directly enhancing the enzyme's kinase activity. | ||||||
Uridine-5′-triphosphate, Trisodium Salt | 19817-92-6 | sc-301964 sc-301964A | 50 mg 1 g | $88.00 $120.00 | 2 | |
UTP (Uridine triphosphate), as a substrate of UCKL1, is essential for the enzyme's activity in catalyzing the conversion to CTP, which is a critical step in pyrimidine biosynthesis. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol, through its inhibition of xanthine oxidase, increases the availability of purines, which can lead to an upregulation of pyrimidine synthesis pathways, indirectly enhancing UCKL1 activity. | ||||||
Inosine | 58-63-9 | sc-295182 sc-295182A | 1 g 5 g | $60.00 $92.00 | ||
Inosine can act as a feedback inhibitor of de novo purine synthesis, which might lead to the upregulation of pyrimidine synthesis, thereby indirectly enhancing UCKL1 activity. | ||||||
Folinic acid calcium salt | 1492-18-8 | sc-252837 sc-252837A | 100 mg 500 mg | $94.00 $375.00 | 3 | |
Leucovorin (Folinic acid) can enhance the biosynthesis of thymidine, a pyrimidine nucleotide, indirectly affecting the activity of UCKL1 by increasing the demand for pyrimidine nucleotides. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate indirectly increases UCKL1 activity by inhibiting dihydrofolate reductase, leading to an accumulation of substrates for thymidylate and subsequently pyrimidine synthesis, in which UCKL1 is involved. | ||||||
AICA-Riboside, 5′-Phosphate | 3031-94-5 | sc-202448B sc-202448C sc-202448 sc-202448A | 5 mg 10 mg 50 mg 100 mg | $184.00 $281.00 $505.00 $938.00 | 1 | |
AICA Ribonucleotide, as an intermediate in purine biosynthesis, can indirectly enhance UCKL1 activity by influencing the balance of purine and pyrimidine nucleotide availability. | ||||||
β-Pyrazofurin Trifluoroacetic Acid Salt | 30868-30-5 (free base) | sc-476809 | 1 mg | $480.00 | ||
Pyrazofurin inhibits orotidylate decarboxylase, which can lead to an accumulation of orotidine, a substrate for UCKL1, thereby enhancing its activity. | ||||||